Apolipoprotein E4 in Parkinson disease and dementia: New data and meta-analysis of published studies

Rivka Inzelberg, J. Chapman, T. A. Treves, A. Asherov, S. Kipervasser, O. Hilkewicz, R. Verchovsky, S. Klimowitzky, A. D. Korczyn

Research output: Contribution to journalArticlepeer-review


The authors examined whether the ε4 allele might be associated with dementia in Parkinson disease (PD), given that the dementia of PD shares neuroanatomic and neurochemical features with Alzheimer disease (AD) and that many recent studies have found a high prevalence of the ε4 allele of apolipoprotein E (ApoE) in AD. The authors examined patients with PD (n = 125, 47 demented) and unrelated controls (n = 93) using a short mental test. DNA was obtained from blood leukocytes. The relevant portion of the apolipoprotein E (ApoE) gene was amplified by polymerase chain reaction, and the ε4 allele was identified using a restriction enzyme. The frequency of the ApoE ε4 allele in demented patients with PD (14%) was not greater than that in non-demented patients (17%), whereas patients with PD as a whole showed a trend toward a higher ε4 allele frequency (16%) than age-matched controls (10%, p = 0.07). The ε4 allele frequency in non-demented patients with PD was significantly higher than in controls (p = 0.055). These results and the meta-analysis of four published reports fail to support the hypothesis that the ε4 allele is associated with dementia in PD.

Original languageEnglish
Pages (from-to)45-48
Number of pages4
JournalAlzheimer Disease and Associated Disorders
Issue number1
StatePublished - Mar 1998


  • Apolipoprotein E
  • Dementia
  • Genotyping
  • Meta-analysis
  • Parkinson's disease


Dive into the research topics of 'Apolipoprotein E4 in Parkinson disease and dementia: New data and meta-analysis of published studies'. Together they form a unique fingerprint.

Cite this